Experimental drug reverses paralysis and vision loss in multiple sclerosis model

A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.

Read it at Medical Xpress ↗

← Front page